Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akynzeo in Refractory CINV
NCT03008213Phase 2Terminated
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV). Primary endpoint: Number of Participants Completed All Study Procedures Over Seven Days at 7 days. Started Jan 2017; status: terminated.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT03008213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008213.